HealthStar names Muratore to succeed Levy
HealthStar has named Bob Muratore as Levy's successor, giving him the new title group president of agency services. Muratore also serves as executive vice president of corporate planning at HealthStar.
Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.
Hires and promotions for manufacturers, regulatory and agencies
The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.